Certain problems during pregnancy—being born much larger than expected and being exposed to a mother’s diabetes—were linked to a slightly higher chance of developing multiple sclerosis (MS) as an adult.
Researchers followed over 1.1 million people born in Norway and found that those born large for their gestational age (LGA) had a modestly higher risk of getting MS as adults compared with babies of average size.Babies born small for gestational age (SGA) showed a slightly lower risk of adult-onset MS compared with average-sized babies.If the mother had diabetes during pregnancy (including some types of diabetes that start in pregnancy), the child’s risk of adult MS was higher—about twice the risk in this study—though the number of people with this exposure was smaller.Other pregnancy problems the study looked at—being born early (preterm), the placenta separating early (placental abruption), and mother’s high blood pressure problems in pregnancy—were not linked to adult MS in this group.The study suggests that some influences on MS risk may begin before birth, similar to how a tree’s early roots can affect how it grows much later in life.
People with MS and their caregivers may find this helpful because it shows that some risk factors for MS can start before birth, which adds to what we know about how MS develops over a lifetime.Expectant parents, especially those managing diabetes, should know this adds another reason to work closely with their healthcare team to control blood sugar in pregnancy; good control can help many aspects of a child’s health.Healthcare providers and neurologists who counsel families might use this information to explain how early-life factors fit with other known risks like childhood obesity.Families with MS who are planning pregnancy can use this as part of broader conversations about maternal health and long-term outcomes for children, even though it doesn’t prove cause-and-effect.Caregivers should not view these results as predicting a child’s fate—think of this like a small shift in odds (like a few extra marbles in a bag) rather than a certainty—and many other factors affect whether someone gets MS.
This study shows associations (links), not proof that being born LGA or exposed to maternal diabetes causes MS; other things could contribute to the difference in risk.The higher risk for maternal diabetes patients came from fewer cases, so the estimate is less certain and needs confirmation in other studies; think of it like a small signpost pointing where to look next.These results come from people born in Norway between 1967 and 1989, so patterns may differ in other countries, more recent births, or populations with different health care and lifestyles.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.